N-Nitrosonornicotine one] 21725-46-2 Cyanazine 10049-04-4 Chlorine dioxide 10061-02-6 trans-1,3-Dichloropropene 10222-01-2 2,2-Dibromo-3-nitrilopropionamide 10294-34-5 Boron trichloride penyl)cyclopropanecarboxylate]] 12122-67-7 Zineb [Carbamodithioic acid, 1,2-ethanediylbis-, zinc complex] 12427-38-2 Maneb [Carbamodithioic acid, 1,2-ethanediylbis-, manganese complex] 13194-48-4 Ethoprop [Phosphorodithioic acid O-ethyl S,S-dipropyl ester] 13356-08-6 Fenbutatin oxide (hexakis(2-methyl-2-phenylpropyl)distannoxane) 13463-40-6 Iron pentacarbonyl 13474-88-9 1,1-Dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc) 13684-56-5 Desmedipham 14484-64-1 Ferbam [Tris(dimethylcarbamo-dithioato-S, S')iron] 15972-60-8❘ Alachlor 16071-86-6 C.I. Direct Brown 95 16543-55-8 17804-35-2 Benomyl 19044-88-3 Oryzalin [4-(Dipropylamino)-3,5-dinitrobenzene-sulfonamide] 19666-30-9 Oxydiazon 20325-40-0 3,3'-Dimethoxybenzidine dihydrochloride (Dianisidine dihydrochloride) 20354-26-1 Methazole [2-(3,4-Dichlorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione] 20816-12-0 | Osmium tetroxide 20859-73-8 Aluminum phosphide 21087-64-9❘ Metribuzin 22781-23-3 Bendiocarb (2,2-Dimethyl-1,3-benzodioxol-4-ol methylcarbamate] 23564-05-8 Thiophanate methyl 23564-06-9 Thiophanate ethyl [[1,2-Phenylenebis(iminocarbonothioyl)]biscarbamic acid diethyl ester] 23950-58-5 Pronamide 1/1/87 1/1/95 1/1/95 1/1/95 [[5-(Phenylmethyl)-3-furanyl]methyl 2,2-dimethyl-3-(2-methyl-1-pro 1/1/95 1/1/87 1/1/87 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/87 1/1/87 1/1/95 1/1/95 [3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H) 1/1/95 1/1/95 1/1/95 1/1/87 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/94 Dinitrotoluene 25311-71-1 Isofenphos [2-[[Ethoxyl[(1-methylethyl)amino]phosphinothioyl)oxy]benzoic acid 1-methylethyl ester] 25321-14-6 1/1/95 26644-46-2 Triforine [N,N'-[1,4-Piperazinediylbis(2,2,2-trichloroethylidene)] bisformamide] 1/1/95 27314-13-2 Norflurazon [4-Chloro-5-(methylamino)-2-[3-(trifluoromethyl)phenyl]- 3(2H)-pyridazinone] 28057-48-9 d-trans-Allethrin [d-trans-Chrysanthemic acid of d-allethrone] 29232-93-7 Pirimiphos methyl (O-(2-(Diethylamino)-6-methyl-4-pyrimidinyl)-O,O-dimethyl phosphorothioate] 30560-19-1 Acephate (Acetylphosphoramidothioic acid O,S-dimethyl ester) 1/1/95 1/1/95 31218-83-4 Propetamphos [3-[[(Ethylamino)methoxyphosphino-thioyl)oxy]-2-butenoic acid, 1-methylethyl ester] 33089-61-1❘ Amitraz 1/1/95 1/1/95 34014-18-1 Terbuthiuron [N-[5-(1,1-Dimethylethyl)-1,3,4-thiadiazol-2-yl)-N,N'- dimethylurea] 35400-43-2 Sulprofos [O-Ethyl O-[4-(methylthio)phenyl]phosphorodithioic acid S-propyl ester] 35554-44-0 Imazalil [1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole] 39515-41-8 Fenpropathrin [2,2,3,3-Tetramethylcyclopropane carboxylic acid cyano(3-phenoxyphenyl)methyl ester] 1/1/95 40487-42-1 41198-08-7 Pendimethalin [N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzen-amine] Profenofos [O-(4-Bromo-2-chlorophenyl)-O-ethyl-S-propyl phosphorothioate] 41766-75-0 3,3'-Dimethylbenzidine dihydrofluoride (ortho-Tolidine dihydrofluoride) 42874-03-3 Oxyfluorfen 1/1/95 1/1/95 1/1/95 1/1/95 Hexazinone 43121-43-3 Triadimefon [1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone] 50471-44-8 Vinclozolin [3-(3,5-Dichlorophenyl)-5-ethenyl-5-methyl-2,4- oxazolidinedione] 51235-04-2 1/1/95 1/1/95 1/1/95 Fenvalerate 51338-27-3 Diclofop methyl [2-[4-(2,4-Dichlorophenoxy)phenoxy]propanoic acid, methyl ester] 51630-58-1 1/1/95 1/1/95 53404-19-6 Bromacil, lithium salt [2,4-(1H,3H)-Pyrimidinedione, 5-bromo-6-methyl-3-(1-methylpropyl), lithium salt] 53404-37-8 2,4-D 2-ethyl-4-methylpentyl ester 1/1/95 1/1/95 1/1/95 53404-60-7 Dazomet, sodium salt (Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione, ion(1-), sodium] 55290-64-7 Dimethipin [2,3,-Dihydro-5,6-dimethyl-1,4-dithiin 1,1,4,4-tetraoxide] 1/1/95 1/1/95 60168-88-9 Fenarimol [.alpha.-(2-Chlorophenyl)-.alpha.-4-chlorophenyl)-5-pyrimidine- methanol] 60207-90-1 Propiconazole [1-[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]-methyl-1H-1,2,4,-triazole] 62476-59-9 Acifluorfen, sodium salt [5-(2-Chloro-4-(trifluoromethyl) phenoxy)-2-nitrobenzoic acid, sodium salt] 62924-70-3 Flumetralin [2-Chloro-N-(2,6-dinitro-4-(trifluoromethyl)-phenyl)-N-ethyl-6-fluorobenzenemethanamine] 63938-10-3 64902-72-3 Chlorsulfuron 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/94 car 1/1/95 1/1/95 cyano(3-phenoxyphenyl)methyl ester] phenoxyphenyl)methyl ester] 66441-23-4 Fenoxaprop ethyl [2-(4-((6-Chloro-2-benzoxazolylen)oxy)phenoxy) propanoic acid, ethyl ester] 67485-29-4 Hydramethylnon [Tetrahydro-5,5-dimethyl-2(1H)-pyrimidinone[3-[4-(trifluoromethyl)phenyl]-1-[2-[4 (trifluoromethyl)phenyl]ethenyl]-2- propenylidene)hydrazone] 68085-85-8 Cyhalothrin [3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2 68359-37-5 Cyfluthrin [3-(2,2-Dichloro-ethenyl)-2,2-dimethylcyclo-propanecarboxylic acid, cyano(4-fluoro-3 69409-94-5 Fluvalinate [N-[2-Chloro-4-(trifluoromethyl)phenyl]-DL-valine (+)-cyano(3-phenoxyphenyl)methylester] 69806-50-4 Fluazifop-butyl [2-[4-[[5-(Trifluoromethyl)-2-pyridinyl)oxy]-phenoxy]propanoic acid, butyl ester] 71751-41-2 Abamectin [Avermectin B1] 1/1/95 1/1/95 72178-02-0 Fomesafen [5-(2-Chloro-4-(trifluoromethyl)phenoxy)-N-methylsulfonyl)-2- nitrobenzamide] 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 1/1/95 methyl 88671-89-0 Myclobutanil [.alpha.-Butyl-.alpha.-(4-chlorophenyl)-1H-1,2,4-triazole- 1-propanenitrile] 90454-18-5 Dichloro-1,1,2-trifluoroethane 90982-32-4 Chlorimuron ethyl [Ethyl-2-[[[(4-chloro-6-methoxyprimidin-2-yl)-carbonyl]-amino]sulfonyl]benzoate] 101200-48-0 Tribenuron methylamino)carbonyl)amino)sulfonyl)-, methyl ester] 111512-56-2 1,1-dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb) 111984-09-9 3,3'-Dimethoxybenzidine hydrochloride (Dianisidine dihydrochloride) 127564-92-5 Dichloropentafluoropropane 1/1/95 1/1/94 1/1/95 [2-(((((4-Methoxy-6-methyl-1,3,5-triazin-2-yl) 1/1/95 1/1/95 1/1/95 1/1/95 128903-21-9 2,2-Dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa) 136013-79-1 1,3-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea) 1/1/95 1/1/95 *Note: CAS No. 6484-52-2 is removed from this listing; the removal is effective July 2, 1995, for the 1995 reporting year. *Note: The listing of 2,2-dibromo-3-nitrilopropionamide (DBNPA) (CAS No. 10222-01-2) is stayed. The stay will remain in effect until further administrative action is taken. (c) Chemical categories in alphabetical order. Category name Effective date Antimony Compounds: Includes any unique chemical substance that contains antimony as part of that chemical's infrastructure 1/1/87 Arsenic Compounds: Includes any unique chemical substance that contains arsenic as part of that chemical's infrastructure 1/1/87 Barium Compounds: Includes any unique chemical substance that contains barium as part of that chemical's infrastructure (except for barium sulfate, (CAS No. 7727-43-7) 1/1/87 Beryllium Compounds: Includes any unique chemical substance that contains beryllium as part of that chemical's infrastructure 1/1/87 Cadmium Compounds: Includes any unique chemical substance that contains cadmium as part of that chemical's infrastructure Chlorophenols 1/1/87 1/1/87 OH -Clx ·H(5-x) Where x=1 to 5 Category name Chromium Compounds: Includes any unique chemical substance that contains chromium as part of that chemical's infrastructure (except for chromite ore mined in the Transvaal Region of South Africa and the unreacted ore component of the chromite ore processing residue (COPR). COPR is the solid waste remaining after aqueous extraction of oxidized chromite ore that has been combined with soda ash and kiln roasted at approximately 2,000 °F.) Cobalt Compounds: Includes any unique chemical substance that contains cobalt as part of that chemical's infrastructure Copper Compounds: Includes any unique chemical substance that contains copper as part of that chemical's infrastructure (except for C.I. Pigment Blue 15 (PB-15, CAS No. 147-14-8), C.I. Pigment Green 7 (PG-7, CAS No. 1328-53-6), and C.I. Pigment Green 36 (PG-36, CAS No. 14302-13-7) except copper phthalocyanine compounds that are substituted with only hydrogen and/or bromine and/or chlorine that meet the following molecular structure definition: Effective date 1/1/87 1/1/87 1/1/87 where R = H and/or Br and/or Cl only.” R R Category name Effective date Cyanide Compounds: x= CN where X = H or any other group where a formal dissociation can be made. For example KCN, or Ca(CN)2 1/1/87 Diisocyanates (This category includes only those chemicals listed below) 1/1/95 038661-72-2 1,3-Bis(methylisocyanate)cyclohexane 010347-54-3 1,4-Bis(methylisocyanate)cyclohexane Category name 002556-36-7 1,4-Cyclohexane diisocyanate 000091-93-0 3,3'-Dimethoxybenzidine-4,4'-diisocyanate 075790-84-0 4-Methyldiphenylmethane-3,4-diisocyanate 003173-72-6 1,5-Naphthalene diisocyanate 000123-61-5 1,3-Phenylene diisocyanate 000104-49-4 1,4-Phenylene diisocyanate 009016-87-9 Polymeric diphenylmethane diisocyanate 016938-22-0 2,2,4-Trimethylhexamethylene diisocyanate 015646-96-5 2,4,4-Trimethylhexamethylene diisocyanate Dioxin and dioxin-like compounds (Manufacturing; and the processing or otherwise use of dioxin and dioxin-like compounds if the dioxin and dioxin-like compounds are present as contaminants in a chemical and if they were created during the manufacturing of that chemical) Effective date 1/00 1/1/94 1/1/95 R' = H or alkyl C7 or less; or OR' consisting of carboxylic acid ester, sulfate, phosphate, nitrate, or sulfonate. Lead Compounds: Includes any unique chemical substance that contains lead as part of that chemical's infrastructure 1/1/87 Manganese Compounds: Includes any unique chemical substance that contains manganese as part of that chemical's infrastructure 1/1/87 Mercury Compounds: Includes any unique chemical substance that contains mercury as part of that chemical's infrastructure 1/1/87 Nicotine and salts 1/1/95 Nitrate compounds (water dissociable; reportable only when in aqueous solution) 1/1/95 Nickel Compounds: Includes any unique chemical substance that contains nickel as part of that chemical's infrastructure 1/1/87 Polybrominated Biphenyls (PBBs) 1/1/87 Polychlorinated alkanes (C10 to C13): Includes those chemicals defined by the following formula: 1/1/95 Cx H2x-y=2 Cly where x= 10 to 13; y= 3 to 12; and where the average chlorine content ranges from 40-70% with the limiting molecular formulas C10 H19 Cl3 and C13 H16 Cl12. Polycyclic aromatic compounds (PACS): (This category includes only those chemicals listed below) Selenium Compounds: Includes any unique chemical substance that contains selenium as part of that chemical's infrastructure 1/1/87 Silver Compounds: Includes any unique chemical substance that contains silver as part of that chemical's infrastruc ture 1/1/87 Strychnine and salts 1/1/95 Thallium Compounds: Includes any unique chemical substance that contains thallium as part of that chemical's infrastructure 1/1/87 Vanadium compounds 1/00 Warfarin and salts 1/1/94 Zinc Compounds: Includes any unique chemical substance that contains zinc as part of that chemical's infrastructure 1/1/87 [53 FR 4525, Feb. 16, 1988; 53 FR 12748, Apr. 18, 1988] EDITORIAL NOTE: For FEDERAL REGISTER citations affecting §372.65, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and on GPO Access. Subpart E-Forms and Instructions § 372.85 Toxic chemical release reporting form and instructions. (a) Availability of reporting form and instructions. The most current version of EPA Form R (EPA Form 9350-1 and subsequent revisions) and the instructions for completing this form may be obtained by writing to the Section 313 Document Distribution Center, P.O. Box 12505, Cincinnati, OH 45212. EPA also encourages facilities subject to this part to submit the required information to EPA by using magnetic media (computer disk or tape) in lieu of Form R. Instructions for submitting and using magnetic media may also be obtained from the address given in this paragraph. (b) Form elements. Information elements reportable on EPA Form R or equivalent magnetic media format include the following: (1) An indication of whether the report: (i) Claims chemical identity as trade secret. (ii) Covers the entire facility or part of a facility. |